Lung Cancer Incidence and Mortality in National Lung Screening Trial Participants Who Underwent Low-Dose CT Prevalence Screening: A Retrospective Cohort Analysis of a Randomised, Multicentre, Diagnostic Screening Trial

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(15)00621-x
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV

Related search

Impact of Low-Dose CT Screening on Smoking Cessation Among High-Risk Participants in the UK Lung Cancer Screening Trial

Thorax
PulmonaryRespiratory Medicine
2017English

Risk Perceptions Among Participants Undergoing Lung Cancer Screening: Baseline Results From the National Lung Screening Trial

Annals of Behavioral Medicine
MedicinePsychiatryMental HealthPsychology
2009English

Low-Dose CT for Lung Cancer Screening

The Lancet Oncology
Oncology
2018English

Small Pulmonary Nodules in Baseline and Incidence Screening Rounds of Low-Dose CT Lung Cancer Screening

Translational Lung Cancer Research
Oncology
2017English

A National Survey of Lung Cancer Specialists’ Views on Low-Dose CT Screening for Lung Cancer in Korea

PLoS ONE
Multidisciplinary
2018English

Low-Dose CT for Lung Cancer Screening – Authors' Reply

The Lancet Oncology
Oncology
2018English

CT Screening for Lung Cancer: Successful Trial, but Failed Understanding

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prolonged Lung Cancer Screening Reduced 10-Year Mortality in the MILD Trial: New Confirmation of Lung Cancer Screening Efficacy

Annals of Oncology
MedicineOncologyHematology
2019English

The (US) National Lung Cancer Screening Trial: Intensifying the Debate About the Introduction of Screening for Lung Cancer

Journal of the Royal College of Physicians of Edinburgh, The
MedicineEducationHistory
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy